Stay updated on ADPKD Tolvaptan Post-Marketing Surveillance Clinical Trial
Sign up to get notified when there's something new on the ADPKD Tolvaptan Post-Marketing Surveillance Clinical Trial page.

Latest updates to the ADPKD Tolvaptan Post-Marketing Surveillance Clinical Trial page
- CheckyesterdayChange DetectedThe history indicates posted results and associated sections (Results, Adverse Events, Outcome Measures, Baseline Characteristics, Participant Flow, Document Section, Study Design, Study Status), replacing the previous Results Submitted entry.SummaryDifference1%

- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedNew revision entry v3.3.2 was added to the Record History and the previous revision v3.3.1 was removed. This appears to be a version-control update with no impact on study data or page content.SummaryDifference0.1%

- Check23 days agoChange DetectedThe page history shows the addition of Revision: v3.3.1 and the removal of Revision: v3.2.0, with no changes to the study data or eligibility/status. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check30 days agoChange DetectedRemoved the banner about the lapse in government funding and the NIH/OPM operating status, which was previously displayed on the page. The notice informing users about potential delays and status updates is no longer shown. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.7%

- Check44 days agoChange DetectedThe Record History shows several version updates with changes to Study Status and Recruitment Status. These updates reflect the ongoing progression and enrollment status of the trial.SummaryDifference0.2%

- Check73 days agoChange DetectedCore content update: introduced operating-status notice and a new version (v3.2.0), replacing the previous v3.1.0; adds funding-related caveats and directs users to status pages.SummaryDifference13%

Stay in the know with updates to ADPKD Tolvaptan Post-Marketing Surveillance Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ADPKD Tolvaptan Post-Marketing Surveillance Clinical Trial page.